Edition:
United Kingdom

HBM Healthcare Investments AG (HBMN.S)

HBMN.S on Swiss Exchange

170.00CHF
16 Oct 2018
Change (% chg)

-- (--)
Prev Close
CHF170.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,828
52-wk High
CHF184.80
52-wk Low
CHF120.10

Chart for

About

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer... (more)

Overall

Beta: 0.49
Market Cap(Mil.): CHF838.46
Shares Outstanding(Mil.): 7.04
Dividend: 5.80
Yield (%): 4.87

Financials

  HBMN.S Industry Sector
P/E (TTM): 10.87 100.38 19.25
EPS (TTM): 10.95 -- --
ROI: 8.26 6.67 0.47
ROE: 9.11 12.16 15.61

BRIEF-HBM Healthcare Investments: Successful IPO Of Y-Mabs Therapeutics

* SUCCESSFUL IPO OF Y-MABS THERAPEUTICS INCREASES NET ASSET VALUE PER HBM-SHARE BY CHF 4.82 (+2.7%) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

24 Sep 2018

BRIEF-HBM Healthcare Investments Invests $15 Million In China's Jianke

* INVESTING USD 15 MILLION IN CHINA'S ONLINE PHARMACY AND HEALTHCARE SERVICES PLATFORM JIANKE

05 Sep 2018

BRIEF-HBM Healthcare Investments Reports Q1 Profit Of CHF 66.6 Mln

* SAYS PROFIT OF CHF 66.6 MILLION FOR FIRST THREE MONTHS TO 30 JUNE 2018

25 Jul 2018

Earnings vs. Estimates